Ocuphire Pharma Inc
For the period ended Jun 30, 2024. Filed Aug 13, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 13, 2024
IRD$4.18+4.4%Stored close · as of Nov 6, 2026
Contents
Item 1. Financial Statements
| Item 1. | Financial Statements |
|---|
Condensed Balance Sheets
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.